CIK: 1336284 - Address: C/o Zoetis Inc., 10 Sylvan Way, Parsippany, NJ 07054
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret1186436296519
P%wins75636375757571
S%ret1160-3-12-14-16-36-16
S%wins6750676710010075

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/22/24 16:52
5/21/24
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDM.d00.00022811D
2/12/24 17:53
2/8/24
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDM.d00.0001228D
2/14/23 16:58
2/11/23
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDM.d00.0002307D
2/15/22 19:58
2/12/22
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDM.d00.0003886D
2/17/21 17:33
2/13/21
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDM.d00.00033254D
9/8/20 16:18
9/4/20
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDS-173159.160-1-431D
8/4/20 17:32
8/3/20
ZTSZoetis Inc.HealthDrugPharmaceutical PreparationsRhodes LindaNJDM.d00.00033D
2/1/16 16:30
1/29/16
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP155.2503667D43-9-47-16-22-26-19-22-5-5-8510-9
4/28/15 18:09
4/27/15
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCS-22515.003-15-3423D741-17-21-7-12-10-2-9-935-56-52
3/6/15 18:34
3/6/15
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCS-40020.004-20-5421D-873501520101-1-5-20-29-6-78
12/23/14 17:06
12/22/14
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCS-18018.006-10-2441D41272483128403632-18-59
10/8/14 17:37
10/6/14
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCM.d286.00351451D-49-30-35-19-1-8-2-20108059-20
7/3/14 16:54
7/1/14
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCS-16016.004-10-2446D120-10-73821916-4-18-37-480-22
6/17/14 18:05
6/17/14
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCS-6915.002-5-1456D-20-136125166-12-31-9-5
6/11/14 18:10
6/9/14
PETXAratana Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRhodes LindaKSOCHIEF SCS-8115.002-5-1461D-22-2361855-222-15-7-1
6/3/14 10:39
6/2/14
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP34.3001194D-26161-6-4243-30-6041570
1/26/11 15:33
1/24/11
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP13.000064D59-25-11-81-6-6-661415212562
12/1/10 12:29
11/29/10
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP13.000063D38-29-28-11-19-8-11-1151119136490
6/30/10 10:04
6/28/10
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP.m13.100073D-839-17-10-12-12-10-10712-675133
2/23/09 14:20
2/19/09
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP.m12.0000153-5-16211467135
10/16/08 09:06
10/13/08
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP12.5001243D-59-53-32-36-33-28-25-171918-3-11-1367
7/18/08 15:43
7/16/08
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDP03.350052D-35-46-1972-5-2-21832-36-43-27
6/19/07 09:59
6/19/07
ICCCImmucell Corp /de/DEHealthDiagnIn Vitro & In Vivo DiagnosticRhodes LindaMEDM.d94.6702New2D4411-392-1000-35-29-38-36

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact